Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McGill University
$105,000.00
Identifying and targeting functional mediators of leptomeningeal metastasis
FY 2018-19
Summary
With recent improvements in the treatment of cancer, patients are living longer than ever before. However, with this comes an increased incidence of spread, or metastasis, to the brain. Brain metastasis is a particularly devastating complication of cancer that results in the death of many patients, especially those with primary cancers of the breast, lung, and skin. A major problem facing the research community is that there are no patient-derived animal models of brain metastasis, rendering it difficult to study brain metastasis and develop new treatments. For this reason, I have established a research program whereby I transplant human brain metastasis specimens from the operating room directly into the brains of mice. In the mouse hosts, the human cancer cells grow and proliferate infinitely, as they would in the patient they came from. Establishing a large number of these human tumour models allows us to better understand brain metastases. With these models, I am working towards understanding how cancer spreads from the primary site, such as the breast, to colonize the brain and spinal cord. Preliminary results from these unique and novel model systems suggests that they can be instrumental in improving our understanding of the molecular processes that allow cancer cells to reach the brain and spinal cord. This knowledge can then be exploited in the form of new therapeutic approaches to prevent or treat brain metastasis.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
404091
Name
Dankner Matthew
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Identifying and targeting functional mediators of leptomeningeal metastasis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Brain Metastasis; Breast Cancer; Cancer; Leptomeningeal Metastasis; Lung Cancer; Melanoma; Metastasis; Neurosurgery; Patient-Derived Xenograft
Abstract
With recent improvements in the treatment of cancer, patients are living longer than ever before. However, with this comes an increased incidence of spread, or metastasis, to the brain. Brain metastasis is a particularly devastating complication of cancer that results in the death of many patients, especially those with primary cancers of the breast, lung, and skin. A major problem facing the research community is that there are no patient-derived animal models of brain metastasis, rendering it difficult to study brain metastasis and develop new treatments. For this reason, I have established a research program whereby I transplant human brain metastasis specimens from the operating room directly into the brains of mice. In the mouse hosts, the human cancer cells grow and proliferate infinitely, as they would in the patient they came from. Establishing a large number of these human tumour models allows us to better understand brain metastases. With these models, I am working towards understanding how cancer spreads from the primary site, such as the breast, to colonize the brain and spinal cord. Preliminary results from these unique and novel model systems suggests that they can be instrumental in improving our understanding of the molecular processes that allow cancer cells to reach the brain and spinal cord. This knowledge can then be exploited in the form of new therapeutic approaches to prevent or treat brain metastasis.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dankner, Matthew
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~